Christopher Bowden

Christopher Bowden

Director/Board Member presso Cedilla Therapeutics, Inc.

63 anni
Health Technology
Consumer Services
Finance

Profilo

Christopher J.
Bowden
is on the board of Cedilla Therapeutics, Inc. Dr. Bowden previously held the position of Chief Medical Officer of Agios Pharmaceuticals, Inc., Executive Director-Europe, Middle East & Africa at Bristol Myers Squibb Co., VP-Product Development Oncology at Genentech, Inc. and Member of Roche Group.
Christopher J.
Bowden
received a doctorate from Drexel University College of Medicine and an undergraduate degree from Lake Forest College.

Posizioni attive di Christopher Bowden

SocietàPosizioneInizio
Director/Board Member 21/04/2021
Tutte le posizioni attive di Christopher Bowden

Precedenti posizioni note di Christopher Bowden

SocietàPosizioneFine
ALAUNOS THERAPEUTICS, INC. Director/Board Member 30/03/2023
AGIOS PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 01/09/2021
VIRIDIAN THERAPEUTICS, INC. Director/Board Member 01/10/2020
Corporate Officer/Principal 01/05/2014
Corporate Officer/Principal 01/01/2014
Vedi nel dettaglio l'esperienza di Christopher Bowden

Formazione di Christopher Bowden

Lake Forest College Undergraduate Degree
Drexel University College of Medicine Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Christopher Bowden

Relazioni

100 +

Relazioni di 1° grado

9

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa4
BRISTOL-MYERS SQUIBB COMPANY

Health Technology

AGIOS PHARMACEUTICALS, INC.

Health Technology

ALAUNOS THERAPEUTICS, INC.

Health Technology

VIRIDIAN THERAPEUTICS, INC.

Health Technology

Aziende private3

Health Technology

Finance

Health Technology

Vedi le connessioni aziendali
  1. Borsa
  2. Insiders
  3. Christopher Bowden